Evidence map›Paper›PMID 31955152›Full record

ArticleAging2020

MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway.

Jian Wang, Mengchan Zhu, Ling Ye, Cuicui Chen, Jun She, Yuanlin Song

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring CTRP6: a biomarker and therapeutic target in metabolic diseases.American journal of physiology. Endocrinology and metabolism · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jian WangDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Mengchan ZhuDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Ling YeDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Cuicui ChenDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Jun SheDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Yuanlin SongDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
The First Affiliated Hospital, Sun Yat-sen University · CNFudan University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory responses are considered to be the critical mechanism underlying particulate matter (PM)-induced development and exacerbation of chronic respiratory diseases. MiR-29b-3p has been found to participate in various biological processes, but its role in PM-induced inflammatory responses was previously unknown. Here, we constructed a miRNA PCR array to find that miR-29b-3p was the most highly expressed in human bronchial epithelial cells (HBECs) exposed to PM. MiR-29b-3p promoted PM-induced pro-inflammatory cytokines (IL-1β, IL-6, and IL-8) expression via inhibiting the AMPK signaling pathway in HBECs. RNA sequencing and luciferase reporter assay identified that miR-29b-3p targeted complement C1q tumor necrosis factor-related protein 6 (C1QTNF6), a protein that protected from PM-induced inflammatory responses via activating the AMPK signaling pathway.

Indexed as

AMP-Activated Protein KinasesAnimalsBiomarkersCollagenDisease Models, AnimalDisease SusceptibilityGene ExpressionHumansImmunohistochemistryInflammationMaleMAP Kinase Signaling SystemMiceMicroRNAsModels, BiologicalParticulate MatterAMP-Activated Protein KinasesBiomarkersC1qTNF6 protein, humanCollagenMicroRNAsMIRN29a microRNA, humanParticulate MatterAMPK pathwaycomplement C1q tumor necrosis factor-related protein 6inflammatory responsesmiR-29b-3pparticulate matter

Identifiers

PMID31955152
PMCPMC7053628
OpenAlexW2998747952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.